Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessrRNA processing

BRIX1 WBP11 EXOSC10 REXO4 NAT10 BMS1 DDX10

1.30e-06230507GO:0006364
GeneOntologyBiologicalProcessribosome biogenesis

BRIX1 WBP11 EXOSC10 REXO4 NAT10 RBIS BMS1 DDX10

1.35e-06336508GO:0042254
GeneOntologyBiologicalProcessribonucleoprotein complex biogenesis

BRIX1 WBP11 EXOSC10 REXO4 NAT10 RBIS BMS1 GEMIN5 DDX10

3.54e-06515509GO:0022613
GeneOntologyBiologicalProcessrRNA metabolic process

BRIX1 WBP11 EXOSC10 REXO4 NAT10 BMS1 DDX10

4.25e-06275507GO:0016072
GeneOntologyCellularComponentprotein kinase CK2 complex

CSNK2A1 CSNK2A3

3.22e-054492GO:0005956
Domain-

EXOSC10 REXO4 GIN1

2.86e-04475133.30.420.10
DomainRNaseH-like_dom

EXOSC10 REXO4 GIN1

8.85e-0469513IPR012337
DomainSer/Thr_kinase_AS

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

2.83e-03357515IPR008271
DomainS_TKc

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

2.90e-03359515SM00220
DomainPROTEIN_KINASE_ST

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

3.01e-03362515PS00108
DomainKinase-like_dom

CSNK2A1 BUB1 MACF1 TAOK1 CAMK1G CSNK2A3

3.46e-03542516IPR011009
DomainProtein_kinase_ATP_BS

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

3.66e-03379515IPR017441
DomainPkinase

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

3.74e-03381515PF00069
DomainPROTEIN_KINASE_ATP

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

8.14e-03459515PS00107
DomainProt_kinase_dom

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

1.05e-02489515IPR000719
DomainPROTEIN_KINASE_DOM

CSNK2A1 BUB1 TAOK1 CAMK1G CSNK2A3

1.09e-02493515PS50011
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

BRIX1 EXOSC10 REXO4 NAT10 NEMF BMS1 DDX60L DDX10

3.31e-0833252825693804
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 GEMIN5 MACF1 DDX10

4.92e-0765352922586326
Pubmed

Human platelets contain forms of factor V in disulfide-linkage with multimerin.

MMRN1 F5

2.19e-06252215583744
Pubmed

Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2.

CSNK2A1 CSNK2A3

2.19e-06252214646071
Pubmed

A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome.

CISD2 WFS1

2.19e-06252225422446
Pubmed

Assignment of casein kinase 2 alpha sequences to two different human chromosomes.

CSNK2A1 CSNK2A3

2.19e-0625221577469
Pubmed

Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.

CSNK2A1 CSNK2A3

2.19e-06252212860116
Pubmed

Identification of the MMRN1 binding region within the C2 domain of human factor V.

MMRN1 F5

2.19e-06252215452129
Pubmed

Molecular cloning of the human casein kinase II alpha subunit.

CSNK2A1 CSNK2A3

2.19e-0625222752008
Pubmed

Structure and sequence of an intronless gene for human casein kinase II-alpha subunit.

CSNK2A1 CSNK2A3

2.19e-0625228420794
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

BRIX1 WBP11 EXOSC10 REXO4 LCORL NAT10 BMS1 DDX10

3.07e-0660552828977666
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

WBP11 EXOSC10 REXO4 CSNK2A1 NAT10 NEMF BMS1 MACF1 PPIP5K2 ZNF292

3.93e-061082521038697112
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

BRIX1 WBP11 EXOSC10 REXO4 WFS1 CSNK2A1 NAT10 NEMF BMS1 TAOK1 DDX10

4.68e-061371521136244648
Pubmed

Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation.

CSNK2A1 CSNK2A3

6.57e-06352215684395
Pubmed

Isolation and characterization of human cDNA clones encoding the alpha and the alpha' subunits of casein kinase II.

CSNK2A1 CSNK2A3

6.57e-0635222174700
Pubmed

Mapping of the human casein kinase II catalytic subunit genes: two loci carrying the homologous sequences for the alpha subunit.

CSNK2A1 CSNK2A3

6.57e-0635221766873
Pubmed

Identification and partial characterization of factor Va heavy chain kinase from human platelets.

CSNK2A1 F5

6.57e-0635229525959
Pubmed

Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.

BRCA2 BUB1

6.57e-06352214646599
Pubmed

Crystallization and preliminary characterization of crystals of human protein kinase CK2.

CSNK2A1 CSNK2A3

6.57e-06352211092945
Pubmed

Sequencing of full-length cDNA encoding the alpha and beta subunits of human casein kinase II from human platelets and megakaryocytic cells. Expression of the casein kinase IIalpha intronless gene in a megakaryocytic cell line.

CSNK2A1 CSNK2A3

6.57e-06352212102635
Pubmed

Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.

MMRN1 F5

6.57e-06352219132231
Pubmed

Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.

CSNK2A1 CSNK2A3

6.57e-06352220625391
Pubmed

STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.

BRIX1 EXOSC10 NAT10 BMS1 CSNK2A3 DDX10

7.69e-0631652631665637
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

TOPAZ1 C19orf53 CSNK2A1 TAOK1 AK9 CSNK2A3 ZNF292

8.95e-0649752736774506
Pubmed

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

MBTD1 EXOSC10 CSNK2A1 NAT10 BMS1 DDX10

1.15e-0533952630415952
Pubmed

Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.

BRIX1 WBP11 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 DDX10

1.22e-0573152829298432
Pubmed

The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.

BRIX1 EXOSC10 REXO4 NAT10 BMS1 DDX10

1.35e-0534952625665578
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

BRIX1 EXOSC10 REXO4 NAT10 NEMF BMS1 MACF1 DDX10

1.60e-0575952835915203
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

BRIX1 WBP11 EXOSC10 REXO4 NAT10 BMS1 MACF1 DDX10

2.48e-0580752822681889
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

MBTD1 HIVEP1 LCORL GEMIN5 RAI2 ZNF292

2.82e-0539852635016035
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

REXO4 HIVEP1 LCORL CSNK2A1 NAT10 ZNF292 DDX10

3.26e-0560852736089195
Pubmed

Human transcription factor protein interaction networks.

BRIX1 MBTD1 WBP11 REXO4 HIVEP1 CSNK2A1 NAT10 BMS1 RAI2 DDX10

4.35e-051429521035140242
Pubmed

A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.

CSNK2A1 CSNK2A3

4.58e-05752211239457
Pubmed

p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.

CSNK2A1 CSNK2A3

6.10e-05852212393879
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

BRIX1 WBP11 EXOSC10 REXO4 C19orf53 NAT10 GEMIN5

6.48e-0567852730209976
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

EXOSC10 REXO4 NAT10 BMS1 DDX10

6.55e-0528352530585729
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

WBP11 EXOSC10 REXO4 HIVEP1 BRCA2 C19orf53 NAT10 DDX10

8.04e-0595452836373674
Pubmed

The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.

BRIX1 EXOSC10 REXO4 NAT10 BMS1 DDX10

8.24e-0548352636912080
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

EXOSC10 BRDT CSNK2A1 NAT10 NEMF MACF1

9.53e-0549652631343991
Pubmed

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.

EXOSC10 NAT10 BMS1 MACF1

9.60e-0515952434578187
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

MBTD1 EXOSC10 HIVEP1 MACF1 KMT2E ZNF181

9.64e-0549752623414517
Pubmed

Autoantibody of NRIP, a novel AChR-interacting protein, plays a detrimental role in myasthenia gravis.

CSNK2A1 MACF1

9.79e-051052233773096
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

BRIX1 WBP11 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 DDX10

1.03e-0498952836424410
Pubmed

Nucleolar maturation of the human small subunit processome.

EXOSC10 NAT10 BMS1

1.12e-046252334516797
Pubmed

Distinct nuclear and cytoplasmic assemblies and interactomes of the mammalian CTLH E3 ligase complex.

BRIX1 EXOSC10 REXO4 BMS1

1.16e-0416752435833506
Pubmed

Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence.

HIVEP1 SH3BP5

1.20e-041152222488850
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

BRIX1 WBP11 EXOSC10 CSNK2A1 NAT10 MACF1 F5 DDX10

1.31e-04102452824711643
Pubmed

Tagging genes with cassette-exchange sites.

MBTD1 GEMIN5 MACF1 RPGR ZNF292

1.44e-0433552515741177
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

SMAP1 EXOSC10 REXO4 DENND6A CISD2 BMS1 RPGR

1.51e-0477752735844135
Pubmed

Systems genetic analysis of hippocampal neuroanatomy and spatial learning in mice.

RBIS GEMIN5

1.97e-041452226449520
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

BRIX1 REXO4 HIVEP1 CSNK2A1 NAT10 NEMF BMS1 GEMIN5 DDX10

2.38e-04142552930948266
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

SMAP1 EXOSC10 CSNK2A1 NAT10 NEMF BMS1

3.05e-0461552631048545
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

BRIX1 WBP11 EXOSC10 CISD2 WFS1 NAT10 BMS1 MACF1 DDX10

3.25e-04148752933957083
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

HIVEP1 BRCA2 LCORL BUB1 GEMIN5

4.00e-0441852534709266
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

BRIX1 WBP11 CSNK2A1 NAT10 MACF1 F5

4.43e-0466052632780723
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

BRIX1 EXOSC10 CSNK2A1 BMS1 DDX10

5.10e-0444152531239290
Pubmed

Functional proteomic analysis of human nucleolus.

EXOSC10 REXO4 NAT10

5.46e-0410652312429849
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

BRIX1 CISD2 C19orf53 CSNK2A1 NEMF BMS1 GEMIN5 MACF1

6.40e-04129752833545068
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

BRIX1 EXOSC10 C19orf53 CSNK2A1 BMS1 GEMIN5

6.64e-0471352629802200
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

BRIX1 CSNK2A1 NAT10 BMS1 GEMIN5 TAOK1 PPIP5K2 DDX10

7.11e-04131852830463901
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

REXO4 NAT10 GEMIN5 MACF1 ZNF292 DDX10

7.19e-0472452636232890
Pubmed

Expressed sequence tag analysis of human RPE/choroid for the NEIBank Project: over 6000 non-redundant transcripts, novel genes and splice variants.

TAOK1 F5 DNAH14

7.27e-0411752312107410
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

EXOSC10 REXO4 NAT10 BMS1 GEMIN5 MACF1 DDX60L DDX10

8.43e-04135352829467282
Pubmed

Cellular heterogeneity in the ureteric progenitor niche and distinct profiles of branching morphogenesis in organ development.

MFSD2A CDCA7 BUB1

9.86e-0413052328705898
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

MBTD1 EXOSC10 NAT10 GEMIN5 MACF1 TAOK1 DEPDC1

1.10e-03108452711544199
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

BRIX1 SMAP1 WBP11 EXOSC10 CSNK2A1 NEMF GEMIN5 MACF1

1.13e-03141552828515276
Pubmed

HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.

GIN1 MACF1

1.19e-033452225925205
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

WBP11 EXOSC10 HIVEP1 LCORL C19orf53 CSNK2A1 ZNF292

1.22e-03110352734189442
Pubmed

Mettl14-mediated m6A modification ensures the cell-cycle progression of late-born retinal progenitor cells.

BRCA2 ZNF292

1.26e-033552237269288
Pubmed

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.

MBTD1 BRCA2 CSNK2A1

1.38e-0314652323892456
Pubmed

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.

WBP11 NAT10 DDX10

1.43e-0314852332538781
Pubmed

Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.

MMRN1 F5

1.49e-033852216263699
InteractionANKRD36C interactions

CSNK2A1 ANKRD36C CSNK2A3

3.51e-0612523int:ANKRD36C
InteractionCHD4 interactions

BRIX1 WBP11 EXOSC10 REXO4 BRCA2 LCORL CSNK2A1 NAT10 BMS1 GEMIN5 CSNK2A3 DDX10

3.55e-069385212int:CHD4
InteractionPOLR1G interactions

BRIX1 WBP11 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 ZNF292 DDX10

3.94e-06489529int:POLR1G
InteractionRPL31 interactions

BRIX1 WBP11 EXOSC10 REXO4 C19orf53 CSNK2A1 NAT10 BMS1 MACF1 DDX10

7.86e-066805210int:RPL31
InteractionH2AB2 interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

8.18e-06107525int:H2AB2
InteractionFGF8 interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

8.56e-06108525int:FGF8
InteractionMNDA interactions

BRIX1 EXOSC10 REXO4 NAT10 BMS1 DDX10

8.67e-06188526int:MNDA
InteractionDNAJC9 interactions

BRIX1 EXOSC10 BRDT NAT10 BMS1 ZNF292 DDX10

1.04e-05296527int:DNAJC9
InteractionIFI16 interactions

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 NEMF BMS1 DDX60L CSNK2A3 DDX10

1.20e-057145210int:IFI16
InteractionPTGES3 interactions

DENND6A BRCA2 GEMIN5 DEPDC1 DDX60L GREB1 PPIP5K2 DDX10

1.50e-05437528int:PTGES3
InteractionMAGEB2 interactions

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 DDX10

3.01e-05349527int:MAGEB2
InteractionF5 interactions

MMRN1 CSNK2A1 F5

3.16e-0524523int:F5
InteractionANOS1 interactions

EXOSC10 REXO4 NAT10 BMS1 DDX10

3.33e-05143525int:ANOS1
InteractionNPM1 interactions

BRIX1 EXOSC10 REXO4 HIVEP1 BRCA2 CSNK2A1 NAT10 BMS1 GEMIN5 RPGR ZNF181 DDX10

4.24e-0512015212int:NPM1
InteractionCDC14B interactions

BRCA2 CSNK2A1 NAT10 BUB1 BMS1

5.37e-05158525int:CDC14B
InteractionZNF2 interactions

BRIX1 REXO4 BMS1 DDX10

5.39e-0580524int:ZNF2
InteractionRPS24 interactions

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 RBIS BMS1 DDX10

5.82e-05529528int:RPS24
InteractionAPEX1 interactions

REXO4 HIVEP1 BRCA2 CDCA7 C19orf53 CSNK2A1 NAT10 BMS1 RPGR DNAH14 ZNF292 DDX10

7.35e-0512715212int:APEX1
InteractionNEIL1 interactions

BRIX1 REXO4 CSNK2A1 NAT10 BMS1 DDX10

7.50e-05276526int:NEIL1
InteractionH1-7 interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

9.69e-05179525int:H1-7
InteractionNOP56 interactions

BRIX1 REXO4 BRDT CSNK2A1 NAT10 NEMF BMS1 DDX10

9.80e-05570528int:NOP56
InteractionSIRT7 interactions

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 GEMIN5 MACF1 DDX10

1.07e-04744529int:SIRT7
InteractionNIFK interactions

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 DDX10

1.14e-04431527int:NIFK
InteractionSRPK3 interactions

BRIX1 EXOSC10 REXO4 NAT10 BMS1

1.28e-04190525int:SRPK3
InteractionZNF330 interactions

WBP11 EXOSC10 REXO4 NAT10 BMS1 ZNF292 DDX10

1.40e-04446527int:ZNF330
InteractionZC3H10 interactions

BRIX1 REXO4 HIVEP1 BMS1 DDX10

1.63e-04200525int:ZC3H10
InteractionDDX18 interactions

BRIX1 REXO4 NAT10 NEMF KMT2E DDX10

2.12e-04334526int:DDX18
InteractionDDX23 interactions

BRIX1 WBP11 REXO4 BRDT NAT10 BMS1 DDX10

2.20e-04480527int:DDX23
InteractionLIN28B interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

2.23e-04214525int:LIN28B
InteractionF2RL3 interactions

CSNK2A1 CSNK2A3

2.32e-049522int:F2RL3
InteractionCT45A3 interactions

CSNK2A1 CSNK2A3

2.32e-049522int:CT45A3
InteractionCCDC140 interactions

BRIX1 REXO4 NAT10 BMS1

2.36e-04117524int:CCDC140
InteractionH1-4 interactions

BRIX1 WBP11 REXO4 WFS1 NAT10 BMS1 MACF1 DDX10

2.56e-04656528int:H1-4
InteractionPNMA8A interactions

BRIX1 NAT10 BMS1 DDX10

2.76e-04122524int:PNMA8A
InteractionMDFIC interactions

BRCA2 CSNK2A1

2.90e-0410522int:MDFIC
InteractionEFCAB14 interactions

CSNK2A1 CSNK2A3

2.90e-0410522int:EFCAB14
InteractionMECP2 interactions

BRIX1 WBP11 EXOSC10 REXO4 CSNK2A1 NAT10 NEMF BMS1 MACF1 PPIP5K2 ZNF292

3.68e-0412875211int:MECP2
InteractionDGCR8 interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

3.93e-04242525int:DGCR8
InteractionFBXO22 interactions

TOPAZ1 C19orf53 CSNK2A1 TAOK1 AK9 CSNK2A3 ZNF292

4.49e-04540527int:FBXO22
InteractionSRPK2 interactions

BRIX1 WBP11 REXO4 HIVEP1 NAT10 BMS1 MACF1 F5

4.65e-04717528int:SRPK2
InteractionMAD2L1 interactions

HIVEP1 BUB1 GEMIN5 MACF1 PPIP5K2

4.73e-04252525int:MAD2L1
InteractionANKRD36B interactions

CSNK2A1 ANKRD36C CSNK2A3

5.00e-0460523int:ANKRD36B
InteractionIPMK interactions

CSNK2A1 CSNK2A3

5.00e-0413522int:IPMK
InteractionHAGHL interactions

CSNK2A1 CSNK2A3

5.00e-0413522int:HAGHL
InteractionFGFBP1 interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

5.17e-04257525int:FGFBP1
InteractionZBTB47 interactions

BRIX1 REXO4 BMS1 DDX10

5.19e-04144524int:ZBTB47
InteractionNPM3 interactions

BRIX1 REXO4 NAT10 BMS1 DDX10

5.64e-04262525int:NPM3
InteractionRTF1 interactions

CSNK2A1 BUB1 GEMIN5 CSNK2A3

6.05e-04150524int:RTF1
InteractionH2BC8 interactions

MBTD1 EXOSC10 REXO4 NAT10 BMS1 ZNF292 DDX10

6.59e-04576527int:H2BC8
InteractionRPL4 interactions

BRIX1 EXOSC10 REXO4 CSNK2A1 NAT10 BMS1 GEMIN5 DDX10

7.06e-04764528int:RPL4
InteractionABT1 interactions

BRIX1 REXO4 CSNK2A1 NAT10 BMS1 DDX10

7.43e-04423526int:ABT1
InteractionPCDH18 interactions

CSNK2A1 CSNK2A3

7.66e-0416522int:PCDH18
Cytoband5q21.1

GIN1 PPIP5K2

2.36e-04205225q21.1
CoexpressionGSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP

MMRN1 SMAP1 DENND6A RPGR KMT2E SH3BP5

2.02e-06193516M7395
CoexpressionAtlasfacebase_RNAseq_e10.5_MandArch_2500_K1

MMRN1 SMAP1 MFSD2A BRCA2 GIN1 NEMF BUB1 RBIS MACF1 DEPDC1 GREB1 RPGR PPIP5K2 ZNF292 DDX10

1.68e-0712415215facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

BRCA2 BRDT LCORL CSNK2A1 BUB1 GEMIN5 TAOK1 GREB1 RPGR PPIP5K2 KMT2E DDX10

2.80e-077765212gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_MedNas_2500_K1

SMAP1 MFSD2A BRCA2 CDCA7 CISD2 GIN1 NAT10 BUB1 MACF1 DEPDC1 GREB1 RPGR ZNF292

1.15e-0610605213facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlasfacebase_RNAseq_e10.5_MandArch_2500

MMRN1 SMAP1 MFSD2A BRCA2 GIN1 NEMF BUB1 RBIS MACF1 DEPDC1 GREB1 RPGR PPIP5K2 ZNF292 DDX10

1.43e-0614685215facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlasfacebase_RNAseq_e10.5_MaxArch_2500_K3

MMRN1 SMAP1 MFSD2A BRCA2 CISD2 CSNK2A1 NAT10 BUB1 DEPDC1 GREB1 RPGR PPIP5K2 ZNF292

7.17e-0612525213facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

SMAP1 MFSD2A BRCA2 CISD2 GIN1 NAT10 NEMF BUB1 MACF1 DEPDC1 RPGR ZNF292 DDX10

7.49e-0612575213facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_MedNas_2500

SMAP1 MFSD2A BRCA2 CDCA7 CISD2 GIN1 NAT10 BUB1 MACF1 DEPDC1 GREB1 RPGR ZNF292

2.63e-0514145213facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

SMAP1 MFSD2A BRCA2 CISD2 GIN1 NAT10 NEMF BUB1 MACF1 DEPDC1 RPGR ZNF292 DDX10

3.65e-0514595213facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlasfacebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1

MFSD2A BRCA2 CDCA7 NAT10 NEMF BUB1 RBIS GEMIN5 DEPDC1 GREB1 DDX10

9.70e-0511645211facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1
CoexpressionAtlasfacebase_RNAseq_e8.5_ParaxMesoderm_2500_K2

MMRN1 BRCA2 CDCA7 CSNK2A1 NAT10 BUB1 RBIS GEMIN5 DEPDC1 GREB1 DDX10

1.05e-0411755211facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

SMAP1 BRCA2 GIN1 NEMF RPGR ZNF292

1.09e-04311526Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000

BRDT LCORL CSNK2A1 GEMIN5 TAOK1 GREB1 RPGR KMT2E DDX10

1.20e-04795529gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000

SMAP1 MFSD2A INTU BRCA2 GIN1 NAT10 NEMF RPGR ZNF292 DDX10

1.22e-049895210Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

MMRN1 MBTD1 LCORL CSNK2A1 TAOK1 GREB1 RPGR PPIP5K2 KMT2E

1.30e-04804529gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasfacebase_RNAseq_e9.5_MandArch_2500_K3

MMRN1 REXO4 BRCA2 CDCA7 CSNK2A1 NAT10 BUB1 GEMIN5 GREB1 PPIP5K2 SH3BP5

1.94e-0412595211facebase_RNAseq_e9.5_MandArch_2500_K3
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000

LCORL TAOK1 GREB1 RPGR PPIP5K2

2.60e-04233525gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_1000

BRDT GEMIN5 DDX10

3.15e-0454523gudmap_developingGonad_P2_ovary_1000_k3
CoexpressionAtlasfacebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500

MFSD2A BRCA2 CDCA7 NAT10 NEMF BUB1 RBIS GEMIN5 DEPDC1 GREB1 DDX10

3.48e-0413475211facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500

BRCA2 BRDT DDX10

3.50e-0456523gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500
CoexpressionAtlasFacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2

MBTD1 EXOSC10 HIVEP1 CISD2 MACF1 RPGR ZNF292

4.27e-04564527Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000

BRDT LCORL GIN1 GEMIN5 TAOK1 GREB1 RPGR DDX10

5.28e-04770528gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_1000

BRDT GEMIN5 DDX10

5.44e-0465523gudmap_developingGonad_e12.5_epididymis_k2_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000

BRDT LCORL GEMIN5 TAOK1 GREB1 RPGR KMT2E DDX10

5.65e-04778528gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_200

LCORL DEPDC1 RAI2

5.68e-0466523gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k3
CoexpressionAtlase8.5_NeuroEpith_nonFloorPlate_top-relative-expression-ranked_500

DENND6A CDCA7 BUB1 RPGR RAI2 DDX10

5.73e-04424526Facebase_ST1_e8.5_NeuroEpith_nonFloorPlate_500
CoexpressionAtlasfacebase_RNAseq_e8.5_ParaxMesoderm_2500

MMRN1 BRCA2 CDCA7 CSNK2A1 NAT10 BUB1 RBIS GEMIN5 DEPDC1 GREB1 DDX10

5.74e-0414295211facebase_RNAseq_e8.5_ParaxMesoderm_2500
CoexpressionAtlasfacebase_RNAseq_e9.5_FaceMes_2500_K4

MMRN1 BRIX1 BRCA2 CDCA7 NAT10 BUB1 GEMIN5 DEPDC1 GREB1

5.75e-04983529facebase_RNAseq_e9.5_FaceMes_2500_K4
CoexpressionAtlase8.5_NeuroEpith_HindBrain_top-relative-expression-ranked_500

CDCA7 BUB1 BMS1 RPGR RAI2 DDX10

6.96e-04440526Facebase_ST1_e8.5_NeuroEpith_HindBrain_500
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000

BRCA2 BRDT GIN1 NAT10 BUB1 BMS1 GEMIN5 DDX10

7.36e-04810528gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlasMESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05

MMRN1 BRIX1 MBTD1 INTU HIVEP1 CDCA7 NAT10 GEMIN5 GREB1 ANKRD36C DDX10

7.65e-0414795211PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05
CoexpressionAtlase9.5_OticVesic_top-relative-expression-ranked_500_4

BUB1 BMS1 RPGR RAI2 DDX10

8.98e-04306525Facebase_ST1_e9.5_OticVesic_500_4
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000

GEMIN5 GREB1 RPGR PPIP5K2

9.64e-04179524gudmap_developingGonad_e14.5_ ovary_1000_k5
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

EXOSC10 BRCA2 NEMF BUB1 DEPDC1 ZNF292

9.69e-04469526Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlasfacebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0

BRCA2 CDCA7 CISD2 BUB1 RBIS DEPDC1 GREB1 PPIP5K2 DDX10

1.12e-031080529facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0
CoexpressionAtlasFetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2

MMRN1 CDCA7 BUB1

1.27e-0387523GSM791122_100
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000

GIN1 BUB1 BMS1 GEMIN5 DDX10

1.31e-03333525gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlasalpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3

CDCA7 BUB1 DEPDC1

1.40e-0390523GSM399403_100
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_500

LCORL TAOK1 RPGR

1.45e-0391523gudmap_developingGonad_e12.5_ovary_k5_500
CoexpressionAtlasFetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3

MMRN1 CDCA7 BUB1

1.49e-0392523GSM791126_100
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5

MFSD2A BRCA2 BUB1 TAOK1

1.56e-03204524Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

HIVEP1 CSNK2A1 GREB1 KMT2E ZNF292

2.97e-06192525916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellSepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class

BRCA2 CDCA7 BUB1 DEPDC1 ANKRD36C

3.62e-06200525f277db6cc288a52a5426120c1067608700ee8ccc
ToppCellmild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1 ANKRD36C

3.62e-0620052563cc57b9331459efbb73051d174d198a3568b938
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MMRN1 AK9 DEPDC1 F5

2.42e-051445247c471e332f87d60f4dbed01f3e66bf39995218d0
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

4.52e-05169524121768fc51fc3441ec725346a1bbe29e21d05971
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

5.06e-05174524c26eac176e9b0cba385630fdc60e0314a4e4caac
ToppCell3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BRCA2 CDCA7 BUB1 DEPDC1

5.06e-0517452446cbb462173a684ceb9e680f9259dc3b133763f7
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

BRCA2 CDCA7 BUB1 DEPDC1

5.18e-051755246b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

SMAP1 MFSD2A LCORL CSNK2A1

5.53e-05178524b1357ceb84b83fab53c0394c1af73cbd009f571a
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 WFS1 BUB1 DEPDC1

5.65e-05179524021d782134126c6f7dce6b6ea50cc54bdaa39987
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

5.77e-05180524f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue

BRCA2 CDCA7 BUB1 DEPDC1

6.03e-051825246745d464c3ff289726aa8164e9a43f407f8e4380
ToppCellE18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass

CDCA7 LCORL GREB1 RAI2

6.16e-05183524de08f9ea02b7244d5a8788064631d10f06565337
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9

EXOSC10 BRCA2 BUB1 DEPDC1

6.16e-05183524f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCellIIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

6.29e-05184524ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1
ToppCellControl-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations)

BRCA2 CDCA7 BUB1 DEPDC1

6.42e-051855249766216b41ee62bbac4caa25cb98ec5627a24075
ToppCellURO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

6.42e-051855240ae9c646679c69a553eda670aef0e0495feb0286
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

6.69e-05187524e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

6.69e-05187524cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

6.83e-051885246c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCellNS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

BRCA2 CDCA7 BUB1 DEPDC1

6.98e-05189524d6bd46abb072b13a6b72f1ca25d19f218cceb1ff
ToppCellILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

BRCA2 RBIS KMT2E ZNF292

6.98e-05189524a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCellInt-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

7.12e-05190524005967c540418b85311308072a07c684f4296aef
ToppCellNS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

INTU BRCA2 BUB1 DEPDC1

7.12e-05190524250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

7.12e-05190524185ae04c68f825cd346aa65072cc5da6a39dff4a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 ANKRD36C

7.12e-0519052431de1727822e9818652946dfb962daee77ffad68
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

7.12e-05190524e38dc41f2e79e3bd51326581c6ebe51927edb549
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

BRCA2 CDCA7 BUB1 DEPDC1

7.27e-05191524210a0f1a71df2508cbfc73d6868a2122338b9a1c
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-05194524f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-0519452417af04acd54dd6a895a966cbb4422de25dc4f1e6
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-05194524a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-0519452417744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCellBLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CDCA7 BUB1 DEPDC1 F5

7.72e-051945246a0cbb9d5c5c4effb02dff654c6c3b184026875c
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-051945243c385d93c5fe1a7817813c492f79fdb94d887357
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-05194524635d0e88f9c542a1d9363066c6cdbc6e44db76c1
ToppCellmoderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

BRCA2 CISD2 BUB1 DEPDC1

7.72e-05194524dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCellControl-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-051945249bbb124001fba7450f4639f47f9b720a483e7242
ToppCellControl-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-05194524844731b7943d1cfca819b7b89e4e62067bfa0230
ToppCellPBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

BRCA2 CDCA7 BUB1 DEPDC1

7.72e-05194524e14f66f7584909621b776292fbd52808273fd2ee
ToppCellHealthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

7.87e-05195524957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCellmild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

BRCA2 CDCA7 BUB1 DEPDC1

7.87e-051955249a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCellInfluenza_Severe-T/NK_proliferative|World / Disease group and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

7.87e-051955246f079c2d7d08110a5e1822ea861b8037eb3f62c9
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BRCA2 CDCA7 BUB1 DEPDC1

8.03e-0519652476f581e35967f8f7c85a8556129f6e8042ad11ca
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MMRN1 BRCA2 BUB1 DEPDC1

8.03e-05196524eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCellHealthy-T/NK_proliferative|Healthy / disease group, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.03e-0519652491e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCellcycling_basal_cell|World / shred by cell class for nasal brushing

BRCA2 CDCA7 BUB1 DEPDC1

8.03e-05196524aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349
ToppCellControl-T/NK_proliferative|Control / Disease condition and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.03e-051965247b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCellsevere-T/NK_proliferative|severe / disease stage, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.03e-0519652489f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCellmild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

BRCA2 CDCA7 BUB1 DEPDC1

8.03e-05196524b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-0519752421861d8b389fafbdb7c3499684c9b6deee3dbd5e
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MMRN1 BRCA2 BUB1 DEPDC1

8.19e-0519752476b61e60a757e58b465569538e632d6d9953e89a
ToppCellsevere_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-05197524189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-051975244b13335a43b9d6abc8e542e72440da7feb82fbe6
ToppCellICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-05197524908e91fa16134b61943aea5e8fc0d6fbac8a8c6e
ToppCellHealthy-T/NK_proliferative|World / disease group, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-05197524e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCellHealthy/Control-T/NK_proliferative|World / Disease group and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-051975244a4d3083938783d6f5b87da02f10e501917da0b4
ToppCellCOVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-05197524718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-051975247eb4c1cffd0366204af7e63adc8f751685601a94
ToppCellsevere-T/NK_proliferative|World / disease stage, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-051975246b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-05197524ffb004c37cdd26cb7cdcd80f769a2eded65416dc
ToppCellHealthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2)

BRCA2 CDCA7 BUB1 DEPDC1

8.19e-05197524b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS|TCGA-Stomach / Sample_Type by Project: Shred V9

BRIX1 REXO4 CSNK2A1 BUB1

8.35e-0519852408f9f05abad4e4078362ea8537c616084cb5d70a
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524ac0be1666456cfa8d68588b187d65008e6d5c0e2
ToppCellCOVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524d484ac79d6cd29f1d9c192d126c2099f737d5320
ToppCellCOVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-0519852448045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-051985245c92687b853ebb00960adbef6552f9d460bc6886
ToppCellCOVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-051985246981cd5b1585c8ae6febdf0c4fb83067127f106c
ToppCellcycling_basal_cell|World / shred by cell class for turbinate

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-0519852448d39018c56ea8ba972c72af8ece10cbeb48fbc8
ToppCell(11)_FOXN4+|World / shred by cell type by condition

BRCA2 BUB1 DEPDC1 RPGR

8.35e-05198524516b1acdf997dd8debc3dca066519366e507b414
ToppCell(0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524c5336d9b802393d6fd6f8446ea4bb6befeb97bfd
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-051985242e669da80363163b806f23a645474d482797ae5d
ToppCellT_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

BRCA2 CDCA7 BUB1 DEPDC1

8.35e-05198524085ba270f9defbf5ef45108c6d870e1d7c428479
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-0519952411c3d9fe811a4619347f47d2b0e94066e3085625
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-0519952488d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCellCOVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-051995249f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCellmild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524d44cc74d7171d96add61dae821daf774b17d4c69
ToppCellproximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-051995242263bb73d9c5693b44d91d2548305efc1b6e4079
ToppCellCOVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCellHealthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-051995241311dfd74b991f48b047a439f04f9bf7dfaa0e7a
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

BRIX1 BRCA2 BUB1 DEPDC1

8.51e-05199524fa698f00d2dad74d28b4696c8c23dce70f123e52
ToppCellproximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524521ff4ae3437c8ba477a0a42b9da195af976c3ff
ToppCellLeuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-0519952487113d398585076ece86b9098781e817f8ca241b
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524e98ff036d04fc78dffef156bdc0d644532274067
ToppCellVE-cycling|VE / Condition, Cell_class and T cell subcluster

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-0519952447c47ebc318a0b98841ca2656837bbd068899559
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCellInfluenza_Severe-T/NK_proliferative|Influenza_Severe / Disease group and Cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-051995242508c55f9ffe17b694c70f1283f41ad4a8e83c00
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-0519952436c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCellVE-cycling-|VE / Condition, Cell_class and T cell subcluster

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524c0a67149a19b65b3069dbc5261d81f658e6e39a2
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCellsevere_influenza-T/NK_proliferative|World / disease group, cell group and cell class (v2)

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-051995241541f655f7d12c650added3683d07e5417a68dfb
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524f315ec3fb6c0799668c9195f836a77fc0db2b615
ToppCellCOVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class

BRCA2 CDCA7 BUB1 DEPDC1

8.51e-05199524ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
DiseaseAutosomal dominant nonsyndromic hearing loss 6

CISD2 WFS1

2.59e-062482cv:C1833021
DiseaseWolfram Syndrome

CISD2 WFS1

2.59e-062482C0043207
DiseaseWolfram syndrome

CISD2 WFS1

2.59e-062482cv:C0043207
DiseaseMENTAL RETARDATION, AUTOSOMAL DOMINANT 40

TAOK1 KMT2E

9.26e-059482C4225275
Diseasecentral nervous system disease (implicated_via_orthology)

GEMIN5 TAOK1

3.06e-0416482DOID:331 (implicated_via_orthology)
DiseaseSeizures

CSNK2A1 MACF1 KMT2E ZNF292

4.37e-04218484C0036572
Diseasehearing impairment

CISD2 WFS1 RPGR

5.51e-0498483C1384666
DiseaseCarcinoma of lung

BRCA2 CSNK2A3

6.41e-0423482C0684249
DiseaseIntellectual Disability

MFSD2A MACF1 TAOK1 KMT2E ZNF292

7.82e-04447485C3714756
DiseaseAutosomal dominant nonsyndromic hearing loss

CISD2 WFS1

1.02e-0329482cv:C5779548
Diseasesensorineural hearing loss (is_implicated_in)

WFS1 F5

1.32e-0333482DOID:10003 (is_implicated_in)
Diseasecholesteryl ester 16:0 measurement

PIRT WFS1

1.58e-0336482EFO_0010341

Protein segments in the cluster

PeptideGeneStartEntry
DAKNKQKFVLKVQKP

BUB1

811

O43683
KRKKNQPELSQKTLK

C2orf78

606

A6NCI8
QLEKKLKRAINKSKP

SH3BP5

196

O60239
KEKSKRNQPKKRKQQ

BRDT

481

Q58F21
QQVKDVQKLRKKEPK

BRIX1

281

Q8TDN6
PKAAKKKKRLLQDLQ

BMS1

16

Q14692
NRPDVKKQKLQNDKK

RAD51AP2

301

Q09MP3
RQQIPEKSQKKKKKT

MRAS

176

O14807
KPIKNRSIKLKKVNS

RAI2

496

Q9Y5P3
PQKQSAQKVIFKKKV

ANKRD36C

1091

Q5JPF3
ELKQIYKKKTNNPIK

nan

1056

O00370
KNKQLQKPQKNKPLL

NEMF

446

O60524
TKKAKVLQKQPLVAK

MBTD1

101

Q05BQ5
NLKLTTQPKKQKHLK

GREB1

176

Q4ZG55
NVVKSQKQVKSLPKK

MMRN1

996

Q13201
QKQVKSLPKKINALK

MMRN1

1001

Q13201
KPEIQNKLLIIKKKA

KIAA2026

716

Q5HYC2
LQKLKNILPKQNKIE

LCORL

451

Q8N3X6
QQKLKKNLEVGIRKK

C19orf53

46

Q9UNZ5
QKRITKKNPKKAEKL

DDX60L

1161

Q5H9U9
PLKEKRKKLKQFQKE

DEPDC1

756

Q5TB30
IQKNKKILKSAKDLP

KMT2E

336

Q8IZD2
INPWVEKKKKIKKQN

NPIPB15

421

A6NHN6
LEAKQEPKQSKKLKN

NAT10

996

Q9H0A0
HIKPQSKKLQVQVKK

MACF1

2196

Q9UPN3
EPTLLKKANKKQNFK

CAMK1G

436

Q96NX5
NPKKLTVIKAKEQLK

INTU

166

Q9ULD6
KKEPKKKKQQLSVCN

MFSD2A

31

Q8NA29
EQKQEKKRLKISKKP

EXOSC10

791

Q01780
NNEKVVVKILKPVKK

CSNK2A3

61

Q8NEV1
KGKKIPKDQKSELIN

BRCA2

601

P51587
PKQVKVKKLKNLKTL

DENND6A

381

Q8IWF6
NNEKVVVKILKPVKK

CSNK2A1

61

P68400
KKPEVRTNKKLLKNN

DNAH14

1866

Q0VDD8
QNKKKQLRKQLKKPE

DDX10

31

Q13206
NEKSLKLSPVQKQKK

RPGR

511

Q92834
SKKKPKIIQQNKKET

REXO4

96

Q9GZR2
LPAQIEKWKLKQKKK

AK9

1161

Q5TCS8
LQNKDKKKKSKPILC

PLCD4

476

Q9BRC7
IKNCPKKTRNLKKIT

F5

326

P12259
VPIIKKKQKHRQKSN

PIRT

111

P0C851
NKSKIIVKKKPKQLN

GIN1

346

Q9NXP7
QPKSLKSKELQIKKQ

TAOK1

711

Q7L7X3
KNKAKPVTTNLKKIN

RBIS

26

Q8N0T1
VPQKDLRVKKNLKKF

CDCA7

6

Q9BWT1
PKKKQQKDSLINLKI

CISD2

61

Q8N5K1
NNKVILLKKEPPKEK

GEMIN5

821

Q8TEQ6
PKTKRKKKNNLENKN

ZNF292

2331

O60281
EKLQKKDQQLEPKKS

SMAP1

191

Q8IYB5
NFKIPLLKNKSEKRK

TOPAZ1

686

Q8N9V7
KLKLKKPKQLQEVLD

PPIP5K2

421

O43314
PQLNEKVLKDKRKKL

WBP11

71

Q9Y2W2
CNLLLKDQKPKKQGK

HIVEP1

391

P15822
DILKKNLPKKSVIKN

ZNF181

186

Q2M3W8
KLNPKKKKQVAVAEL

WFS1

186

O76024